Immunogenicity of Concentrated and Purified Inactivated Avian Influenza Vaccine Formulation

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

NAZARI A.; Samianifard m.; KHALILI I.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Archives of Razi Institute Year:2018 | Volume:73 | Issue:4 Page(s): 319-324

Download Full-Text

View:

239

Download:

Cites:

Information Journal Paper

Title

Immunogenicity of Concentrated and Purified Inactivated Avian Influenza Vaccine Formulation

Author(s)

NAZARI A. | Samianifard m. | KHALILI I. | Issue Writer Certificate

Keywords

Avian H9N2 Influenza Virus

Vaccine

Immunogenicity

Ultrafiltration

Abstract

Avian influenza (AI) H9N2 is a low pathogenic virus subtype belonging to Orthomyxoviridae family. Given the prevalence of this subtype as an infectious agent in poultry industry, special attention has been always directed toward the development of Vaccine production against this infection. The Vaccine of this infection is produced by killing the virus and using a mixture of inactivated antigen and oil phase. Egg-based viral antigens have high levels of unwanted proteins that may adversely affect the Vaccine formulation. In addition, it is required to raise the antigen concentration for the production of combination Vaccines, especially in low doses. This underscores the need to the improvement of the downstream purification process and concentration of antigens. The optimization of downstream processing would decrease the cost of Vaccine procurement and maintenance. Regarding this, the present study was conducted to evaluate a downstream procedure for the concentration and purification of avian influenza virus (H9N2) and investigate the Immunogenicity of the Vaccine containing these antigens. To this end, after harvesting and clarifying virus-containing allantoic fluid, it was concentrated and purified using Ultrafiltration and chromatography, respectively. The concentrated and purified samples were checked for their ovalbumin level and emulsified with oil adjuvant to access their Immunogenicity. The results showed that one dose of both formulated antigens (i. e., concentrated and purified) was effective in raising the immune response in the vaccinated chicks for a long time. The applied formulation had a one-year stability in the refrigerator. Furthermore, the concentrated antigen showed a high hemagglutination activity through a year when storing in the refrigerator. Based on the findings, the optimization of downstream process of influenza (H9N2) Vaccine production and use of new technologies could be considered in the large-scale preparation of a sustainable Vaccine without any unwanted risk factors.

Multimedia

No record.

Cites

No record.

References

No record.

Cite

APA: Copy

NAZARI, A., Samianifard, m., & KHALILI, I.. (2018). Immunogenicity of Concentrated and Purified Inactivated Avian Influenza Vaccine Formulation. ARCHIVES OF RAZI INSTITUTE, 73(4), 319-324. SID. https://sid.ir/paper/725653/en

Vancouver: Copy

NAZARI A., Samianifard m., KHALILI I.. Immunogenicity of Concentrated and Purified Inactivated Avian Influenza Vaccine Formulation. ARCHIVES OF RAZI INSTITUTE[Internet]. 2018;73(4):319-324. Available from: https://sid.ir/paper/725653/en

IEEE: Copy

A. NAZARI, m. Samianifard, and I. KHALILI, “Immunogenicity of Concentrated and Purified Inactivated Avian Influenza Vaccine Formulation,” ARCHIVES OF RAZI INSTITUTE, vol. 73, no. 4, pp. 319–324, 2018, [Online]. Available: https://sid.ir/paper/725653/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops

No record.